BR9504004A - Composto processo para sua preparação e composição farmacêutica - Google Patents
Composto processo para sua preparação e composição farmacêuticaInfo
- Publication number
- BR9504004A BR9504004A BR9504004A BR9504004A BR9504004A BR 9504004 A BR9504004 A BR 9504004A BR 9504004 A BR9504004 A BR 9504004A BR 9504004 A BR9504004 A BR 9504004A BR 9504004 A BR9504004 A BR 9504004A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- pharmaceutical composition
- compound process
- compounds
- oxazole
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 230000008878 coupling Effects 0.000 abstract 1
- 238000010168 coupling process Methods 0.000 abstract 1
- 238000005859 coupling reaction Methods 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 229940126904 hypoglycaemic agent Drugs 0.000 abstract 1
- 150000003839 salts Chemical group 0.000 abstract 1
- 150000003557 thiazoles Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30524994A | 1994-09-13 | 1994-09-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9504004A true BR9504004A (pt) | 1996-09-24 |
Family
ID=23180015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9504004A BR9504004A (pt) | 1994-09-13 | 1995-09-12 | Composto processo para sua preparação e composição farmacêutica |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0702015B1 (pt) |
| JP (1) | JPH08109183A (pt) |
| KR (1) | KR960010649A (pt) |
| CN (1) | CN1130186A (pt) |
| AT (1) | ATE158585T1 (pt) |
| AU (1) | AU3055295A (pt) |
| BR (1) | BR9504004A (pt) |
| CA (1) | CA2157950A1 (pt) |
| CO (1) | CO4410332A1 (pt) |
| CZ (1) | CZ229595A3 (pt) |
| DE (1) | DE69500758T2 (pt) |
| DK (1) | DK0702015T3 (pt) |
| ES (1) | ES2108550T3 (pt) |
| FI (1) | FI954257A7 (pt) |
| GR (1) | GR3025405T3 (pt) |
| HU (1) | HUT73432A (pt) |
| IL (1) | IL115235A0 (pt) |
| MY (1) | MY132008A (pt) |
| NO (1) | NO953569L (pt) |
| NZ (1) | NZ272976A (pt) |
| PE (1) | PE50296A1 (pt) |
| PL (1) | PL310372A1 (pt) |
| SI (1) | SI0702015T1 (pt) |
| SK (1) | SK111195A3 (pt) |
| TR (1) | TR199501115A2 (pt) |
| ZA (1) | ZA957699B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002083863A2 (en) | 2001-04-17 | 2002-10-24 | Sepracor, Inc. | Thiazole and other heterocyclic ligands and use thereof |
| DE10333935A1 (de) * | 2003-07-25 | 2005-02-24 | Aventis Pharma Deutschland Gmbh | Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| FR2858321B1 (fr) * | 2003-07-28 | 2006-01-20 | Servier Lab | Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1249992A (en) * | 1983-11-10 | 1989-02-14 | Marcel Muller | Oxazolidines |
| EP0590793B1 (en) * | 1992-08-31 | 1999-10-13 | Sankyo Company Limited | Oxazolidine derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses |
| US5321036A (en) * | 1993-02-10 | 1994-06-14 | Bristol-Myers Squibb Company | Thiazole and oxazole-based β3 adrenergic receptor agonists |
| WO1994022857A1 (fr) * | 1993-04-07 | 1994-10-13 | Taiho Pharmaceutical Co., Ltd. | Derive de thiazolidine et composition pharmaceutique contenant ce derive |
-
1995
- 1995-09-06 SK SK1111-95A patent/SK111195A3/sk unknown
- 1995-09-07 CZ CZ952295A patent/CZ229595A3/cs unknown
- 1995-09-11 PL PL95310372A patent/PL310372A1/xx unknown
- 1995-09-11 AT AT95810561T patent/ATE158585T1/de not_active IP Right Cessation
- 1995-09-11 AU AU30552/95A patent/AU3055295A/en not_active Abandoned
- 1995-09-11 NZ NZ272976A patent/NZ272976A/en unknown
- 1995-09-11 EP EP95810561A patent/EP0702015B1/en not_active Expired - Lifetime
- 1995-09-11 NO NO953569A patent/NO953569L/no unknown
- 1995-09-11 PE PE1995278667A patent/PE50296A1/es not_active Application Discontinuation
- 1995-09-11 DK DK95810561.1T patent/DK0702015T3/da active
- 1995-09-11 FI FI954257A patent/FI954257A7/fi not_active Application Discontinuation
- 1995-09-11 ES ES95810561T patent/ES2108550T3/es not_active Expired - Lifetime
- 1995-09-11 IL IL11523595A patent/IL115235A0/xx unknown
- 1995-09-11 DE DE69500758T patent/DE69500758T2/de not_active Expired - Fee Related
- 1995-09-11 SI SI9530038T patent/SI0702015T1/xx unknown
- 1995-09-11 CA CA002157950A patent/CA2157950A1/en not_active Abandoned
- 1995-09-11 JP JP7257240A patent/JPH08109183A/ja active Pending
- 1995-09-11 KR KR1019950029478A patent/KR960010649A/ko not_active Withdrawn
- 1995-09-11 MY MYPI95002690A patent/MY132008A/en unknown
- 1995-09-12 HU HU9502663A patent/HUT73432A/hu unknown
- 1995-09-12 BR BR9504004A patent/BR9504004A/pt not_active Application Discontinuation
- 1995-09-12 TR TR95/01115A patent/TR199501115A2/xx unknown
- 1995-09-12 CN CN95115726A patent/CN1130186A/zh active Pending
- 1995-09-12 CO CO95041744A patent/CO4410332A1/es unknown
- 1995-09-13 ZA ZA957699A patent/ZA957699B/xx unknown
-
1997
- 1997-11-19 GR GR970403050T patent/GR3025405T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE50296A1 (es) | 1996-12-05 |
| ES2108550T3 (es) | 1997-12-16 |
| NO953569L (no) | 1996-03-14 |
| IL115235A0 (en) | 1995-12-31 |
| CN1130186A (zh) | 1996-09-04 |
| SI0702015T1 (en) | 1998-02-28 |
| HU9502663D0 (en) | 1995-11-28 |
| DK0702015T3 (da) | 1998-01-12 |
| KR960010649A (ko) | 1996-04-20 |
| HUT73432A (en) | 1996-07-29 |
| ZA957699B (en) | 1997-03-13 |
| SK111195A3 (en) | 1997-06-04 |
| CO4410332A1 (es) | 1997-01-09 |
| EP0702015A1 (en) | 1996-03-20 |
| FI954257A7 (fi) | 1996-03-14 |
| CZ229595A3 (en) | 1996-04-17 |
| NZ272976A (en) | 1996-09-25 |
| CA2157950A1 (en) | 1996-03-14 |
| MY132008A (en) | 2007-09-28 |
| JPH08109183A (ja) | 1996-04-30 |
| EP0702015B1 (en) | 1997-09-24 |
| FI954257A0 (fi) | 1995-09-11 |
| DE69500758D1 (de) | 1997-10-30 |
| PL310372A1 (en) | 1996-03-18 |
| ATE158585T1 (de) | 1997-10-15 |
| TR199501115A2 (tr) | 1996-06-21 |
| GR3025405T3 (en) | 1998-02-27 |
| AU3055295A (en) | 1996-03-28 |
| NO953569D0 (no) | 1995-09-11 |
| DE69500758T2 (de) | 1998-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO180583C (no) | Arylsulfonamido-substituerte hydroksamsyrer, farmasöytiske preparater inneholdende forbindelsene og anvendelse av forbindelsene for fremstilling av farmasöytiske preparater | |
| BR0009864A (pt) | Composto, composição farmacêutica, métodos para o tratamento de doenças, para o tratamento e/ou prevenção de condições mediadas pelos receptores nucleares e para o tratamento e/ou prevenção de diabete e/ou obesidade, e, uso de um composto | |
| BR0309546A (pt) | Composto, composição farmacêutica que compreende o mesmo, processo para a sua preparação e utilização e método para tratamento profilático ou terapêutico de diabetes do tipo ii | |
| AU7815791A (en) | Heterocyclene derivatives | |
| BR9609888A (pt) | Halogenobenzimidazóis | |
| ES2132415T3 (es) | Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol. | |
| FI945975A0 (fi) | Haarautuneella aminoryhmällä substituoituja tiatsoleja, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia | |
| ATE170530T1 (de) | Thiazolidinderivate, ihre herstellung und medikamente, die sie enthalten | |
| NZ334961A (en) | Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same | |
| BR8201264A (pt) | Compostos processo para a preparacao de derivados de 1-aril-2-azolil-etano composicoes microbicidas e processo para o combate ou protecao de uma infestacao de plantas de cultura por microorganismos fitopatogenicos | |
| DK0472501T3 (da) | Codeinsalt af en substitueret carboxylsyre, fremgangsmåde til dets fremstilling, dets anvendelse samt farmaceutiske præparater | |
| SI0843967T1 (en) | Use of Beta-aminopropionic acid derivatives as fungicides | |
| BR9502062A (pt) | Composto processo para a sua preparaçao e composiçao farmaceutica | |
| BR9504004A (pt) | Composto processo para sua preparação e composição farmacêutica | |
| ITMI911853A1 (it) | Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono. | |
| PT99468A (pt) | Processo para a preparacao de compostos cefem 7-actil-3-(carbamoiloxi substituido) com propriedades antibacterianas | |
| FI911138A0 (fi) | Ny substituerad aminfoerening och foerfarande foer dess framstaellning. | |
| PT1123937E (pt) | Substancia gm-95 processo para a sua preparacao e a sua utilizacao | |
| SE7909514L (sv) | Nya halofenyl-pyridyl-allylaminderivat | |
| BR9302809A (pt) | Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral | |
| DK0677513T3 (da) | Octahydro-2-naphthalencarboxylsyrederivat, dets fremstilling og anvendelse | |
| KR920016441A (ko) | 글리세르알데하이드-3-펜타나이드 및 이의 제조방법 | |
| KR960004322A (ko) | 알파-(4-클로로페닐)-4-((4-플루오로페닐)메틸)피페리딘-1-에탄올에스테르,그것의제법및치료학적적용 | |
| ATE360614T1 (de) | Verbindung für die behandlung von atherosclerotischen und thrombotischen erkrankungen | |
| ATE109454T1 (de) | Catecholaminester. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law |